Data / Form D filings / BEAT BioTherapeutics Corp
BEAT BioTherapeutics Corp: Form D filing
BEAT BioTherapeutics Corp, a biotechnology company in Bellevue, WA, filed a Form D with the SEC in 2013. The latest, on April 16, 2013, reports $2.4 million sold of a $2.5 million offering to 21 investors.
Find out what BEAT BioTherapeutics Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1380 - 112TH AVE. NE, SUITE 200, Bellevue, WA, 98004
- Phone
- (425) 269-3478
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1574133
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 16, 2013 | New notice | $2,500,000 | $2,400,000 | $100,000 | 21 | Apr 8, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jim Leggett | Director | |
| Craig Tall | Director | |
| Michael Kranda | Executive Officer, Director | |
| Greg Mahairas, Ph.D. | Executive Officer, Director |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Apr 15, 2013 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BEAT BioTherapeutics Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.